Skip to content

G-Tech Feasibility Study for Early Detection of a Post-op Ileus

Measurement Of GI Myoelectric Activity In Patients At Risk For Or Who Have A Post-Operative Ileus (POI) - Monitoring/ Recording GI Myoelectric Activity For Early Detection of A POI

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02673671
Acronym
GTECHPOI
Enrollment
150
Registered
2016-02-04
Start date
2016-02-29
Completion date
2023-12-31
Last updated
2023-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative Ileus

Brief summary

This feasibility study is for the purpose of determining if the G-Tech Device can differentiate between normal return of GI activity post-operatively and the myoelectric activity in patients who develop a POI.

Detailed description

While preventing the development of a POI is most important, POIs still occur; therefore, it is important to definitively diagnose a POI as early as possible during the post-operative course for treatment to prevent patient discomfort, complications, and extended hospital stay. The purpose of the G-Tech study is to determine if the G-Tech Device can detect a difference in the myoelectric signals from patients who develop a POI compared to those patients who do not develop a POI. It is anticipated that up to 20% of patients enrolled in this study and consented preoperatively, excluding screen failures, will show evidence of a post-operative ileus as detected by the G-Tech GutCheck Device and differentiate the myoelectric signals from the patients who do not develop a POI. Patients who are known to have developed a POI may also be selected for the study.

Interventions

DEVICEG-Tech Myoelectric recording device

A minimum of three patches are placed on the abdomen of the patient to record myoelectric activity.

Sponsors

Eminence Clinical Research, Inc.
CollaboratorINDUSTRY
G-Tech Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Willing and able to provide informed consent; 2. Eighteen (18) years of age or older; 3. Subject is willing and able to follow all study requirements; 4. Subject who will undergo or has undergone open or laparoscopic gastrointestinal surgery or surgery not involving the abdominal cavity.

Exclusion criteria

1. Subject is pregnant or suspects pregnancy; 2. Known allergy to medical grade adhesive; 3. Weight \> 350 lbs (159 Kg);

Design outcomes

Primary

MeasureTime frameDescription
Myoelectric activity pattern in POI patients versus non-POI patientsUp to 6 DaysThe resumption of motor activity in the stomach, small intestine, and colon post-operatively. The measurement is myoelectric signals measured at the skin surface similar to ECG recordings for the heart

Secondary

MeasureTime frameDescription
Anticipated Adverse EventsUp to 6 daysDevice related anticipated adverse events; such as, skin irritation due to adhesive from the skin patch.
UADEsUp to 6 DaysUnanticipated adverse device effects
Device SuccessUp to 6 DaysDevice success defined as the ability to record GI myoelectric activity following GI surgery.

Countries

United States

Contacts

Primary ContactSteve Axelrod, PhD
steve.axelrod@gtechhealth.com650-269-1479

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026